Frontiers

Agmatine Augmentation in Treatment-Resistant Obsessive-Compulsive Disorder: A Prospective Open-Label Case Series

The final, formatted version of the article will be published soon. Abstract Importance: Obsessive-compulsive disorder (OCD) remains treatment-resistant in 40-60% of patients despite adequate trials ...

Addex Therapeutics: Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder ...

Data published in Molecular Psychiatry Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, February 3, 2026 - Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage ...
TMCnet

Addex Announces Publication of Preclinical Data Supporting Potential of mGlu7 Negative Allosteric Modulators to Transform Anxiety and Fear-Related Disorder Tre…

Ciobanu, A.C., Caseiro, D.M., Niu, R. et al. Negative allosteric modulation of mGlu7 disrupts fear memory reconsolidation and ...
Everyday Health on MSN

I tried Brave Health’s online therapy and found it accessible — but it could use some improvements

I tried Brave Health, an online therapy platform designed to bring mental health care to the underserved. Here’s what they ...